LATEST
GTCR agreed to acquire CCC Intelligent SolutionsnewEQT agreed to acquire StockbridgenewProofpoint agreed to acquire VaronisnewPyrophyte Acquisition . II / SakuuMotown Acquisition agreed to acquire Penske Automotive GroupVivos Therapeutics / SOD SciencesAtlasClear Holdings agreed to acquire Ark Financial ServicesLaboratory of America Holdings / BioReference HealthMubadala Capital acquired Clear Channel OutdoorIthaca Holdings agreed to acquire BumblePenta Fine Ingredients acquired SynerzineHexagon agreed to acquire Rocscience
Open App
ClosedPublished 16 Jun 2026

Zydus Lifesciences Ltd. /
Assertio Holdings, Inc.

Zydus completes tender offer for Assertio

Buy side: Zydus Lifesciences Ltd.
Buy sideZydus Lifesciences Ltd.
Target: Assertio Holdings, Inc.
TargetAssertio Holdings, Inc.
Zydus Lifesciences Ltd. · 16 Jun 2026Source
See the source
Follow Zydus Lifesciences Ltd. Follow Assertio Holdings, Inc.
Buy side: Zydus Lifesciences Ltd.
Buy sideZydus Lifesciences Ltd.
Target: Assertio Holdings, Inc.
TargetAssertio Holdings, Inc.
01 / BuyerZydus Lifesciences Ltd.
02 / TargetAssertio Holdings, Inc.
Source for the buyer and target: Zydus Lifesciences Ltd.

For the buyer and target.

“Zydus Lifesciences Ltd. (the “Company”) today announced the successful completion of the cash tender offer, through its wholly-owned subsidiary, Zara Merger Sub Inc. (the “Purchaser”) for all the outstanding shares of common stock of Assertio Holdings, Inc. (Nasdaq: ASRT) (“Assertio”).”

Published 16 Jun 2026

Open the source
01

What happened

Zydus Lifesciences Ltd. has completed its cash tender offer, made through Zara Merger Sub Inc., for the outstanding shares of Assertio Holdings, Inc. The offer was priced at $23.50 per share, without interest, less any required withholding taxes. [01]

As of the expiration of the offer on June 15, 2026, about 66.32% of Assertio's issued and outstanding shares had been validly tendered. A merger of Zara Merger Sub into Assertio is planned for June 16, 2026. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Zydus Lifesciences Ltd.

Zydus completes tender offer for Assertio

This document is the source for the companies, stage, figure and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Also stated

    “As of the expiration of the offer on June 15, 2026, about 66.32% of Assertio's issued and outstanding shares had been validly tendered”

    Open the source

  2. Also stated

    “A merger of Zara Merger Sub into Assertio is planned for June 16, 2026”

    Open the source

  3. Published by Zydus Lifesciences Ltd.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.

04

Deal Web

Every firm and person on this deal, and how they connect. Open any name to see their other deals.

Deal Web · 2 firms · 0 peopleHover a name to see how it connects
This dealZydus Lifesciences Ltd. / Assertio Holdings, Inc.Closed · Published 16 Jun 2026
BuyerZydus Lifesciences Ltd.TargetAssertio Holdings, Inc.
This dealZydus Lifesciences Ltd. / Assertio Holdings, Inc.

Closed · Zydus Lifesciences Ltd. / Assertio Holdings, Inc. deal (Closed, published 16 Jun 2026).

Published 16 Jun 2026
Timeline
  1. Also stated
  2. Also stated
  3. Published by Zydus Lifesciences Ltd.
Hover or tap a name to see how it connects, and when
Deal Web as a list